 | 40O | 表記: | (1R,2R)-cyclohexane-1,2-diol | 組成式: | C6 H12 O2 | SMILES: | OC1CCCCC1O | InChi: | InChI=1S/C6H12O2/c7-5-3-1-2-4-6(5)8/h5-8H,1-4H2/t5-,6-/m1/s1 | 定義日: | 2015-01-06 | 最終更新日: | 2024-09-27 | 公開日: | 2015-07-15 | 識別子(ID): | (1R,2R)-cyclohexane-1,2-diol |
|
 | 40T | 表記: | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | 組成式: | C12 H18 N4 O5 | SMILES: | O=C(N(CC(=O)O)CC(N)C)CN1C=C(C(=O)NC1=O)C | InChi: | InChI=1S/C12H18N4O5/c1-7-3-16(12(21)14-11(7)20)5-9(17)15(4-8(2)13)6-10(18)19/h3,8H,4-6,13H2,1-2H3,(H,18,19)(H,14,20,21)/t8-/m0/s1 | 定義日: | 2010-04-26 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
 | QEW | 表記: | 1-[6-(6-methoxyisoquinolin-7-yl)-1,3-benzothiazol-2-yl]-3-(2-oxidanylideneethyl)urea | 組成式: | C20 H16 N4 O3 S | SMILES: | COc1cc2ccncc2cc1c3ccc4nc(NC(=O)NCC=O)sc4c3 | InChi: | InChI=1S/C20H16N4O3S/c1-27-17-9-12-4-5-21-11-14(12)8-15(17)13-2-3-16-18(10-13)28-20(23-16)24-19(26)22-6-7-25/h2-5,7-11H,6H2,1H3,(H2,22,23,24,26) | 定義日: | 2022-10-26 | 最終更新日: | 2024-09-27 | 公開日: | 2023-03-01 | 識別子(ID): | 1-[6-(6-methoxyisoquinolin-7-yl)-1,3-benzothiazol-2-yl]-3-(2-oxidanylideneethyl)urea |
|
 | QF0 | 表記: | (3S)-3-amino-4-(naphthalen-2-yl)butanoic acid | 組成式: | C14 H15 N O2 | SMILES: | O=C(O)CC(N)Cc1ccc2ccccc2c1 | InChi: | InChI=1S/C14H15NO2/c15-13(9-14(16)17)8-10-5-6-11-3-1-2-4-12(11)7-10/h1-7,13H,8-9,15H2,(H,16,17)/t13-/m0/s1 | 定義日: | 2022-06-07 | 最終更新日: | 2024-09-27 | 公開日: | 2023-06-14 | 識別子(ID): | (3S)-3-amino-4-(naphthalen-2-yl)butanoic acid |
|
 | 412 | 表記: | (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE | 組成式: | C12 H18 B N3 O3 | SMILES: | OCC1OB(OC1)c2ccc(cc2)CCNC(=[N@H])N | InChi: | InChI=1S/C12H18BN3O3/c14-12(15)16-6-5-9-1-3-10(4-2-9)13-18-8-11(7-17)19-13/h1-4,11,17H,5-8H2,(H4,14,15,16)/t11-/m1/s1 | 定義日: | 2005-06-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | 1-(2-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl)guanidine |
|
 | QFG | 表記: | {(4E)-2-[(1E)-4-amino-4-oxobutanimidoyl]-4-benzylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 組成式: | C16 H16 N4 O4 | SMILES: | O=C1C(N=C(C(=[N@H])CCC(=O)N)N1CC(=O)O)=C/c2ccccc2 | InChi: | InChI=1S/C16H16N4O4/c17-11(6-7-13(18)21)15-19-12(8-10-4-2-1-3-5-10)16(24)20(15)9-14(22)23/h1-5,8,17H,6-7,9H2,(H2,18,21)(H,22,23)/b12-8+,17-11+ | 別名: | CHROMOPHORE (GLN-PHE-GLY) | 定義日: | 2011-10-13 | 最終更新日: | 2024-09-27 | 識別子(ID): | {(4E)-2-[(1E)-4-amino-4-oxobutanimidoyl]-4-benzylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | 41H | 表記: | (betaS)-beta-methyl-L-phenylalanine | 組成式: | C10 H13 N O2 | SMILES: | O=C(O)C(N)C(c1ccccc1)C | InChi: | InChI=1S/C10H13NO2/c1-7(9(11)10(12)13)8-5-3-2-4-6-8/h2-7,9H,11H2,1H3,(H,12,13)/t7-,9-/m0/s1 | 定義日: | 2015-01-09 | 最終更新日: | 2024-09-27 | 公開日: | 2016-02-03 | 識別子(ID): | (betaS)-beta-methyl-L-phenylalanine |
|
 | 41Q | 表記: | 4-imino-L-homoserine | 組成式: | C4 H8 N2 O3 | SMILES: | O=C(O)C(N)CC(=[N@H])O | InChi: | InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1 | 定義日: | 2015-01-15 | 最終更新日: | 2024-09-27 | 公開日: | 2015-10-07 | 識別子(ID): | 4-imino-L-homoserine |
|
 | T9M | 表記: | N~2~-acetyl-N-prop-2-en-1-yl-D-allothreoninamide | 組成式: | C9 H16 N2 O3 | SMILES: | N(C(C)=O)C(C(=O)NCC=C)C(C)O | InChi: | InChI=1S/C9H16N2O3/c1-4-5-10-9(14)8(6(2)12)11-7(3)13/h4,6,8,12H,1,5H2,2-3H3,(H,10,14)(H,11,13)/t6-,8+/m0/s1 | 定義日: | 2020-03-18 | 最終更新日: | 2024-09-27 | 公開日: | 2020-04-15 | 識別子(ID): | N~2~-acetyl-N-prop-2-en-1-yl-D-allothreoninamide |
|
 | 420 | 表記: | N-[2-({[5-(DIMETHYLAMINO)NAPHTHALEN-1-YL]SULFONYL}AMINO)ETHYL]-2-IODOACETAMIDE | 組成式: | C16 H20 I N3 O3 S | SMILES: | ICC(=O)NCCNS(=O)(=O)c1cccc2c1cccc2N(C)C | InChi: | InChI=1S/C16H20IN3O3S/c1-20(2)14-7-3-6-13-12(14)5-4-8-15(13)24(22,23)19-10-9-18-16(21)11-17/h3-8,19H,9-11H2,1-2H3,(H,18,21) | 定義日: | 2009-10-19 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-[2-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)ethyl]-2-iodoacetamide |
|
 | T9P | 表記: | N~2~-acetyl-N~1~-prop-2-en-1-yl-L-aspartamide | 組成式: | C9 H15 N3 O3 | SMILES: | N(C(CC(N)=O)C(NCC=C)=O)C(C)=O | InChi: | InChI=1S/C9H15N3O3/c1-3-4-11-9(15)7(5-8(10)14)12-6(2)13/h3,7H,1,4-5H2,2H3,(H2,10,14)(H,11,15)(H,12,13)/t7-/m0/s1 | 定義日: | 2020-03-18 | 最終更新日: | 2024-09-27 | 公開日: | 2020-04-15 | 識別子(ID): | N~2~-acetyl-N~1~-prop-2-en-1-yl-L-aspartamide |
|
 | 424 | 表記: | (2S,4R)-1-[1-(4-chlorophenyl)cyclopropyl]carbonyl-4-(2-chlorophenyl)sulfonyl-N-[1-(iminomethyl)cyclopropyl]pyrrolidine-2-carboxamide | 組成式: | C25 H25 Cl2 N3 O4 S | SMILES: | O=S(=O)(c1ccccc1Cl)C5CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C4(c3ccc(Cl)cc3)CC4)C5 | InChi: | InChI=1S/C25H25Cl2N3O4S/c26-17-7-5-16(6-8-17)25(11-12-25)23(32)30-14-18(35(33,34)21-4-2-1-3-19(21)27)13-20(30)22(31)29-24(15-28)9-10-24/h1-8,15,18,20,28H,9-14H2,(H,29,31)/b28-15+/t18-,20+/m1/s1 | 定義日: | 2010-10-15 | 最終更新日: | 2024-09-27 | 識別子(ID): | (4R)-1-{[1-(4-chlorophenyl)cyclopropyl]carbonyl}-4-[(2-chlorophenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-L-prolinamide |
|
 | 427 | 表記: | (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE | 組成式: | C10 H14 B N3 O3 | SMILES: | OCC1OB(OC1)c2ccc(NC(=[N@H])N)cc2 | InChi: | InChI=1S/C10H14BN3O3/c12-10(13)14-8-3-1-7(2-4-8)11-16-6-9(5-15)17-11/h1-4,9,15H,5-6H2,(H4,12,13,14)/t9-/m1/s1 | 定義日: | 2005-06-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | 1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}guanidine |
|
 | TA1 | 表記: | TAXOL | 組成式: | C47 H51 N O14 | SMILES: | O=C(c1ccccc1)NC(c2ccccc2)C(O)C(=O)OC5C(=C4C(OC(=O)C)C(=O)C7(C(C(OC(=O)c3ccccc3)C(O)(C4(C)C)C5)C6(OC(=O)C)C(OC6)CC7O)C)C | InChi: | InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1 | 定義日: | 2001-07-05 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2beta,5beta,7alpha,8alpha,10alpha,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate |
|
 | TA2 | 表記: | (2R,3S)-3-AMINO-3-PHENYLPROPANE-1,2-DIOL | 組成式: | C9 H11 N O3 | SMILES: | OCC(O)C(N)c1ccccc1 | InChi: | InChI=1S/C9H11NO3/c10-7(8(11)9(12)13)6-4-2-1-3-5-6/h1-5,7-8,11H,10H2,(H,12,13)/t7-,8+/m0/s1 | 定義日: | 2006-09-22 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2R,3S)-3-amino-3-phenylpropane-1,2-diol |
|
 | TA4 | 表記: | (S)-2-[4-(AMINOMETHYL)-1H-1,2,3-TRIAZOL-1-YL]-4-METHYLPENTANOIC ACID | 組成式: | C9 H16 N4 O2 | SMILES: | O=C(O)C(n1nnc(c1)CN)CC(C)C | InChi: | InChI=1S/C9H16N4O2/c1-6(2)3-8(9(14)15)13-5-7(4-10)11-12-13/h5-6,8H,3-4,10H2,1-2H3,(H,14,15)/t8-/m0/s1 | 定義日: | 2004-08-13 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2S)-2-[4-(aminomethyl)-1H-1,2,3-triazol-1-yl]-4-methylpentanoic acid |
|
 | TAJ | 表記: | taccalonolide AJ | 組成式: | C34 H46 O14 | SMILES: | C[CH]1C[C]2(O)OC(=O)[C](C)(O)[C]2(C)[CH]3[CH](O)[CH]4[CH]5[CH](O)C(=O)[CH]6C[CH]7O[CH]7[CH](OC(C)=O)[C]6(C)[CH]5[CH](OC(C)=O)[CH](OC(C)=O)[C]4(C)[CH]13 | InChi: | InChI=1S/C34H46O14/c1-11-10-34(43)32(7,33(8,42)29(41)48-34)21-18(11)31(6)19(24(21)40)17-20(26(44-12(2)35)28(31)46-14(4)37)30(5)15(22(38)23(17)39)9-16-25(47-16)27(30)45-13(3)36/h11,15-21,23-28,39-40,42-43H,9-10H2,1-8H3/t11-,15-,16+,17+,18+,19-,20-,21+,23-,24-,25+,26+,27+,28+,30+,31-,32+,33-,34+/m1/s1 | 定義日: | 2015-12-01 | 最終更新日: | 2024-09-27 | 公開日: | 2017-01-11 |
|
 | 42X | 表記: | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-[2-(propanoylamino)ethyl]-beta-alaninamide | 組成式: | C14 H28 N3 O8 P | SMILES: | O=P(OCC(C(O)C(=O)NCCC(=O)NCCNC(=O)CC)(C)C)(O)O | InChi: | InChI=1S/C14H28N3O8P/c1-4-10(18)15-7-8-16-11(19)5-6-17-13(21)12(20)14(2,3)9-25-26(22,23)24/h12,20H,4-9H2,1-3H3,(H,15,18)(H,16,19)(H,17,21)(H2,22,23,24)/t12-/m0/s1 | 定義日: | 2015-01-23 | 最終更新日: | 2024-09-27 | 公開日: | 2016-01-27 | 識別子(ID): | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-[2-(propanoylamino)ethyl]-beta-alaninamide |
|
 | 42Y | 表記: | O-propanoyl-L-serine | 組成式: | C6 H11 N O4 | SMILES: | O=C(OCC(C(=O)O)N)CC | InChi: | InChI=1S/C6H11NO4/c1-2-5(8)11-3-4(7)6(9)10/h4H,2-3,7H2,1H3,(H,9,10)/t4-/m0/s1 | 定義日: | 2015-01-23 | 最終更新日: | 2024-09-27 | 公開日: | 2016-01-27 | 識別子(ID): | O-propanoyl-L-serine |
|
 | 432 | 表記: | O-butanoyl-L-serine | 組成式: | C7 H13 N O4 | SMILES: | O=C(OCC(C(=O)O)N)CCC | InChi: | InChI=1S/C7H13NO4/c1-2-3-6(9)12-4-5(8)7(10)11/h5H,2-4,8H2,1H3,(H,10,11)/t5-/m0/s1 | 定義日: | 2015-01-23 | 最終更新日: | 2024-09-27 | 公開日: | 2016-01-27 | 識別子(ID): | O-butanoyl-L-serine |
|
 | TAR | 表記: | D(-)-TARTARIC ACID | 組成式: | C4 H6 O6 | SMILES: | O=C(O)C(O)C(O)C(=O)O | InChi: | InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2S,3S)-2,3-dihydroxybutanedioic acid |
|
 | TAU | 表記: | 2-AMINOETHANESULFONIC ACID | 組成式: | C2 H7 N O3 S | SMILES: | O=S(=O)(O)CCN | InChi: | InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) | 定義日: | 2001-12-05 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-aminoethanesulfonic acid |
|
 | TB2 | 表記: | (4-tert-butylphenyl)acetaldehyde | 組成式: | C12 H16 O | SMILES: | O=CCc1ccc(cc1)C(C)(C)C | InChi: | InChI=1S/C12H16O/c1-12(2,3)11-6-4-10(5-7-11)8-9-13/h4-7,9H,8H2,1-3H3 | 定義日: | 2011-03-16 | 最終更新日: | 2024-09-27 | 識別子(ID): | (4-tert-butylphenyl)acetaldehyde |
|
 | TBE | 表記: | TAZOBACTAM INTERMEDIATE | 組成式: | C10 H14 N4 O5 S | SMILES: | O=S(=O)C(Cn1nncc1)(C)C(C(=O)O)N/C=CC=O | InChi: | InChI=1S/C10H14N4O5S/c1-10(20(18)19,7-14-5-4-12-13-14)8(9(16)17)11-3-2-6-15/h2-6,8,11,20H,7H2,1H3,(H,16,17)/b3-2-/t8-,10-/m0/s1 | 定義日: | 2004-07-28 | 最終更新日: | 2024-09-27 | 識別子(ID): | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine |
|
 | TBF | 表記: | TERT-BUTYL FORMATE | 組成式: | C5 H10 O2 | SMILES: | O=COC(C)(C)C | InChi: | InChI=1S/C5H10O2/c1-5(2,3)7-4-6/h4H,1-3H3 | 別名: | TERTIARY BUTOXY CARBONYL | 定義日: | 2003-12-18 | 最終更新日: | 2024-09-27 | 識別子(ID): | tert-butyl formate |
|